Injection of pace: the insulin delivery devices market spikes

Novo Nordisk, Eli Lilly and Medtronic, with a combined market share of approximately 50%, dominate the global insulin delivery devices market.



  • 1-injection-of-pace.jpg
  • 1-injection-of-pace-1.jpg
  • 2-injection-of-pace.jpg
  • 2-injection-of-pace-1.jpg
  • 3-injection-of-pace.jpg
  • 3-injection-of-pace-1.jpg
  • 4-injection-of-pace.jpg
  • 4-injection-of-pace-1.jpg
Related Article
Recommended Whitepaper

View More